147 related articles for article (PubMed ID: 25275029)
1. Prognostic significance of high mobility group box 1 (HMGB1) expression in patients with colorectal cancer.
Ueda M; Takahashi Y; Shinden Y; Sakimura S; Hirata H; Uchi R; Takano Y; Kurashige J; Iguchi T; Eguchi H; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Anticancer Res; 2014 Oct; 34(10):5357-62. PubMed ID: 25275029
[TBL] [Abstract][Full Text] [Related]
2. RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.
Imaoka H; Toiyama Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Carcinogenesis; 2015 Mar; 36(3):346-54. PubMed ID: 25568185
[TBL] [Abstract][Full Text] [Related]
3. Microarray analysis reveals that high mobility group A1 is involved in colorectal cancer metastasis.
Takahashi Y; Sawada G; Sato T; Kurashige J; Mima K; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Eguchi H; Sudo T; Sugimachi K; Tanaka J; Kudo SE; Doki Y; Mori M; Mimori K
Oncol Rep; 2013 Sep; 30(3):1488-96. PubMed ID: 23835740
[TBL] [Abstract][Full Text] [Related]
4. [Expressions and clinical significance of high mobility group box-1 mRNA and protein in laryngeal squamous cell carcinoma tissues and serum].
Guo Y; Liu Y; Tan PQ; Li G; Su ZW; Tian YQ; Qiu YZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jun; 47(6):487-90. PubMed ID: 22932142
[TBL] [Abstract][Full Text] [Related]
5. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S
Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967
[TBL] [Abstract][Full Text] [Related]
6. Predicting lymph node metastasis in early colorectal cancer using the CITED1 expression.
Nasu T; Oku Y; Takifuji K; Hotta T; Yokoyama S; Matsuda K; Tamura K; Ieda J; Yamamoto N; Takemura S; Nakamura Y; Yamaue H
J Surg Res; 2013 Nov; 185(1):136-42. PubMed ID: 23746764
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma.
Yao X; Zhao G; Yang H; Hong X; Bie L; Liu G
J Cancer Res Clin Oncol; 2010 May; 136(5):677-84. PubMed ID: 19898867
[TBL] [Abstract][Full Text] [Related]
8. Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer.
Zhang Z; Wang M; Zhou L; Feng X; Cheng J; Yu Y; Gong Y; Zhu Y; Li C; Tian L; Huang Q
J Exp Clin Cancer Res; 2015 May; 34(1):51. PubMed ID: 25986235
[TBL] [Abstract][Full Text] [Related]
9. Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo.
Dong YD; Cui L; Peng CH; Cheng DF; Han BS; Huang F
Oncol Rep; 2013 Jan; 29(1):87-94. PubMed ID: 23042506
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.
Zhou T; Zhang GJ; Zhou H; Xiao HX; Li Y
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):229-33. PubMed ID: 24150523
[TBL] [Abstract][Full Text] [Related]
12. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
[TBL] [Abstract][Full Text] [Related]
14. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.
Okugawa Y; Inoue Y; Tanaka K; Toiyama Y; Shimura T; Okigami M; Kawamoto A; Hiro J; Saigusa S; Mohri Y; Uchida K; Kusunoki M
Oncol Rep; 2013 Sep; 30(3):1449-54. PubMed ID: 23784200
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of chemokine receptor CXCR3 expression in colorectal carcinoma.
Wu Z; Han X; Yan J; Pan Y; Gong J; Di J; Cheng Z; Jin Z; Wang Z; Zheng Q; Wang Y
Biomed Pharmacother; 2012 Jul; 66(5):373-7. PubMed ID: 22401929
[TBL] [Abstract][Full Text] [Related]
16. Mismatch repair system and p53 expression in patients with T1 and T2 colorectal cancer: predictive role of lymph node metastasis and survival.
Huh JW; Kim HC; Kim SH; Park YA; Cho YB; Yun SH; Lee WY; Chun HK
J Surg Oncol; 2014 Jun; 109(8):848-52. PubMed ID: 24623275
[TBL] [Abstract][Full Text] [Related]
17. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
18. Visinin-like protein-1 overexpression is an indicator of lymph node metastasis and poor prognosis in colorectal cancer patients.
Akagi T; Hijiya N; Inomata M; Shiraishi N; Moriyama M; Kitano S
Int J Cancer; 2012 Sep; 131(6):1307-17. PubMed ID: 22052372
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
20. HMGB1 attenuates anti-metastatic defense of the lymph nodes in colorectal cancer.
Moriwaka Y; Luo Y; Ohmori H; Fujii K; Tatsumoto N; Sasahira T; Kuniyasu H
Pathobiology; 2010; 77(1):17-23. PubMed ID: 20185963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]